Updated January 29 at 9:29pm
Life Sciences
37 results total, viewing 11 - 20
The Rhode Island Foundation awarded $125,000 in grants to fund work on shoreline protection and the shellfish industry by the Coastal Resources Center at the University of Rhode Island’s Graduate School of Oceanography. more
President and CEO of NsGene talks about the value of locating the company in Providence. more
The recent change in leadership at IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, reflects its changing direction, according to those familiar with the company. more
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the four winners of its second annual Rhode Island Bioscience Awards. more
Moderna Therapeutics has announced another record venture capital investment: $450 million. more
Venture capital firm SV Life Sciences has acquired a majority interest in Ximedica from co-founders Stephen Lane and Aidan Petrie. more
Voyager Therapeutics, a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system, has entered into a strategic collaboration with MassBiologics of the University of Massachusetts Medical School. more
The Bill and Melinda Gates Foundation has awarded a $100,000 grant to the GAIA Vaccine Foundation to raise awareness about the prevention of cervical cancer in West Africa. more
Leaders of Neighborhood Health Plan of Rhode Island say strong growth of the company’s patient base, staff and revenue highlight growing community needs prioritized by nationwide health care reform. more
Kimberly Kowal Arcand, a native Rhode Islander, is helping the world understand what exists beyond the Earth’s orbit. She works with NASA’s Chandra X-ray Observatory, creating exhibits of the images it captures. more
« Prev | 1 | 2 | 3 | 4 Next »